$25.33
0.271.08%
Last update: 2:48 PM
15 minutes delayed
Nurix Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-11 | $-0.71 | $-0.64 | -10.9 % |
Mar 2024 | 2024-04-10 | $-0.76 | $-0.80 | 5.00 % |
Dec 2023 | 2024-02-15 | $-0.77 | $-0.57 | -35.1 % |
Sep 2023 | 2023-10-12 | $-0.68 | $-0.76 | 10.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-11 | $12.09M | $22.89M | -47.2 % |
Mar 2024 | 2024-04-10 | $16.59M | $16.64M | -0.33 % |
Dec 2023 | 2024-02-15 | $15.16M | $22.26M | -31.9 % |
Sep 2023 | 2023-10-12 | $18.47M | $17.23M | 7.18 % |
Nurix Therapeutics (NRIX) is scheduled to report earnings on October 10, 2024. The last reported earnings were for reported on July 11, 2024 for Q2.
The Actual EPS was $-0.71, which missed the estimate of $-0.64.
The Actual Revenue was $12.1M, which missed the estimate of $22.9M.
Browse earnings estimates, EPS, and revenue on all stocks.